Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-0.900%
-0.04
-0.900%
-
 
09:32 / Stuttgart Stock Exchange WKN: A2PZG1 / Name: Precigen / Stock / Electrical Utilities & IPPs / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Precigen

sharewise wants to provide you with the best news and tools for Precigen, so we directly link to the best financial data sources.

News

Precigen Q1 Earnings Call Highlights
Precigen Q1 Earnings Call Highlights

Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025

What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?

On July 1, 2026, Precigen (NASDAQ:PGEN) Chief Financial Officer Harry Thomasian Jr. reported the sale of 200,000 shares of common stock in multiple open-market transactions between June 29 and July

Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?

Harry Thomasian Jr. Chief Financial Officer of Precigen (NASDAQ:PGEN), reported the sale of 41,884 shares of common stock on May 28, 2026, as disclosed in the SEC Form 4 filing.

Transaction value